Multiplex Analysis of Clinical Imaging & Biomarker Data to Validate Novel Endpoints for Diabetic Retinopathy
Time: 1:30 pm
day: Conference Day Two
Details:
- Discussing the diagnostic value of ocular fluid biomarkers
- Assessing the value of multimodal imaging in diabetic retinopathy
- Planning phase III clinical studies diabetic retinopathy
